FDA Import Refusal 799-8045242-0/22/1 — Cipla Ltd

Cipla Ltd — FEI 3008725713

The FDA refused shipment 799-8045242-0/22/1 from Cipla Ltd (India) on Jun 20, 2025. The refused product falls under Drugs and Biologics — CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC). Cited charges: 118,75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
Jun 20, 2025
Country
India
Product Category
Drugs and Biologics
Product Code
61XCL45 CETIRIZINE HYDROCHLORIDE (ANTI-HISTAMINIC)
Charges
118,75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.